Edwards Lifesciences Cost of Revenue Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 114.67  1.59  1.41%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Cost of Revenue of Edwards Lifesciences Corporation with missing and latest data points interpolated. Cost of Revenue is found on Edwards Lifesciences income statement and represents the costs associated with goods and services Edwards Lifesciences provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. The aggregate cost of goods produced and sold and services rendered during the reporting period.
Cost of Revenue  10 Years Trend  
Increasing
Slightly volatile
 Cost of Revenue 
      Timeline 

Edwards Lifesciences Cost of Revenue Over Time

2015-12-31  617,200,000 
2016-12-31  797,400,000 
2017-12-31  744,526,316 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  517,585,526
Geometric Mean  499,008,415
Coefficient Of Variation  28.86
Mean Deviation  119,064,035
Median  491,000,000
Standard Deviation  149,384,026
Range  473,700,000
R Value  0.95
R Squared  0.9
Significance  0.00000252
Slope  39,313,600

Currently Trending

AJRD   
 NYQ 
Purchased over 90 shares of
few hours ago ago
Traded for 34.4
I   
 NYQ 
Purchased over 90 shares of
few hours ago ago
Traded for 6.4
CBAY   
 NCM 
Purchased over 90 shares of
few hours ago ago
Traded for 8.14